George Kruse
Psychiatry · Bronx, NYNPI 1417030289
Payments from drug & device makers
Across 1,559 payments — averaging $759.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$695K
- Johnson & Johnson$409K
- E.r. Squibb & Sons, L.L.C.$80K
- Otsuka America Pharmaceutical, Inc.$166
- Neurocrine Biosciences, Inc.$57
- Vanda Pharmaceuticals Inc.$40
- plus $201 from 9 others
What the payments were for
- Consulting fees$21,5202%
- Speaking & faculty fees$937,96879%
- Travel & lodging$195,37616%
- Food & beverage$29,8113%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 921 | $695,347 |
| Johnson & Johnson | 528 | $409,258 |
| E.r. Squibb & Sons, L.L.C. | 83 | $79,618 |
| Otsuka America Pharmaceutical, Inc. | 5 | $166 |
| Neurocrine Biosciences, Inc. | 4 | $57 |
| Vanda Pharmaceuticals Inc. | 3 | $40 |
| Sunovion Pharmaceuticals Inc. | 4 | $39 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $31 |
| Lundbeck LLC | 2 | $29 |
| Indivior Inc. | 2 | $27 |
| AbbVie | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,453,620
- ARISTADA$1,294,240
- INVEGA SUSTENNA$401,894
- INVEGA TRINZA$396,255
- ARISTADA INITIO$305,976
- COBENFY$67,508
- ABILIFY MAINTENA$120
- INVEGA$117
How this compares
$1,184,687 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 53 | $1,157 |
| Sertraline Hcl | 33 | $766 |
| Oxcarbazepine | 16 | $757 |
| Clozapine | 14 | $752 |
| Propranolol Hcl | 28 | $551 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 18 | $496 |
| Buspirone Hcl | 11 | $450 |
| Quetiapine Fumarate | 48 | $350 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $327 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $313 |
| Duloxetine Hcl | 11 | $214 |
| Lamotrigine | 12 | $212 |
| Paroxetine Hcl | 16 | $191 |
| Nortriptyline Hcl | 20 | $187 |
| Alprazolam | 46 | $181 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Bronx
- Elyssa BarronWhite Plains$12.8M
- Mark DibuonoStaten Island$11.9M
- Ronald BrennerHempstead$11.5M
- Anton PorsteinssonRochester$7.6M
- Michael LiebowitzNew York$7.1M
- Leslie CitromePomona$5.7M
- John KaneGlen Oaks$4M
- Inna Yuryev-GolgerBrooklyn$3M
- Subhdeep VirkBuffalo$3M
- Paul EderNew York$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.